It's normal skincare business is quite good as a standalone, so the latest foray into medicinal cannabis is a terrific addition. I bought this company after the IPO and have been keen to see how they are going to grow what has been essentially a sales and distribution business.
The selling point for the business was the sales and distribution ability and with such a low market capitalisation, I felt that it was a fair punt to take for me.
It's normal skincare business is quite good as a standalone, so...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BOD (ASX) Chart |
Day chart unavailable